NCT06771193 Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy
| NCT ID | NCT06771193 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MSD Italia S.r.l. |
| Condition | Cervical Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-12-17 |
| Primary Completion | 2025-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-12-17 with a primary completion date of 2025-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Multicenter, Observational, Retrospective charts review. Observational study with descriptive purpose only. Retrospective data capture in consecutive patients diagnosed with CC who attended the Oncologic Clinics from Jan 2018 to Dec 2021 (using medical records, either electronic or not), inserted in eCRF and analyzed.
Eligibility Criteria
Inclusion Criteria: * Patient (or their legally acceptable representatives) must have signed and dated the Informed Consent \& Privacy Form (ICF) * Age ≥18 years * Diagnosis of a cervical cancer * Locally advanced stage (not suitable for curative surgery) or recurrent or metastatic disease * Any treatment received between January 2018 and December 2021 for advanced disease Exclusion Criteria: * Patients participating in a pharmacological clinical trial for the treatment of advanced disease * Patients who participated in a clinical trial * Patients who were administered with Pembrolizumab, Olaparib or Levantinib or medications from these class of drugs
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06771193 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Cervical Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06771193 currently recruiting?
Yes, NCT06771193 is actively recruiting participants. Contact the research team at info.studiclinici@opisresearch.com for enrollment information.
Where is the NCT06771193 trial being conducted?
This trial is being conducted at Bologna, Italy, Catania, Italy, Genova, Italy, Milan, Italy and 7 additional locations.
Who is sponsoring the NCT06771193 clinical trial?
NCT06771193 is sponsored by MSD Italia S.r.l.. The trial plans to enroll 200 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.